XML 54 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
LOANS RECEIVABLE AND OTHER INVESTMENTS (Tables)
12 Months Ended
Dec. 31, 2018
REAL ESTATE LOANS RECEIVABLE [Abstract]  
Loans Receivable and Other Investments
As of December 31, 2018 and 2017, the Company’s loans receivable and other investments consisted of the following (dollars in thousands):
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2018
 
 
Investment
 
Quantity
as of
December 31, 2018
 
Property Type
 
Principal Balance as of December 31, 2018 (1)
 
Book Value
as of
December 31, 2018
 
Book Value
as of
December 31, 2017
 
Weighted Average Contractual Interest Rate / Rate of Return
 
Weighted Average Annualized Effective Interest Rate / Rate of Return
 
Maturity Date
as of
December 31, 2018
Loans Receivable:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage
 
1

 
Specialty Hospital
 
$
18,577

 
$
18,577

 
$
12,351

 
10.0
%
 
10.0
%
 
01/31/27
Construction
 
2

 
Senior Housing
 
4,569

 
4,629

 
2,733

 
8.0
%
 
7.7
%
 
04/30/21- 09/30/22
Mezzanine
 
1

 
Skilled Nursing
 
23,952

 
2,188

 
10,239

 
10.0
%
 
41.9
%
 
05/25/20
Pre-development
 

 
Senior Housing
 

 

 
2,357

 
N/A

 
N/A

 
N/A
Other
 
18

 
Multiple
 
49,394

 
45,324

 
38,324

 
7.3
%
 
8.1
%
 
02/28/19- 08/31/28
 
 
22

 
 
 
96,492

 
70,718

 
66,004

 
8.5
%
 
9.7
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loan loss reserve
 
 
 
 
 

 
(1,258
)
 
(97
)
 
 
 
 
 
 
 
 
 
 
 
 
$
96,492

 
$
69,460

 
$
65,907

 
 
 
 
 
 
Other Investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preferred Equity
 
9

 
Skilled Nursing / Senior Housing
 
43,851

 
44,262

 
48,483

 
12.1
%
 
12.1
%
 
N/A
Total
 
31

 
 
 
$
140,343

 
$
113,722

 
$
114,390

 
9.6
%
 
10.6
%
 
 

(1) 
Principal balance includes amounts funded and accrued but unpaid interest/preferred return and excludes capitalizable fees.
Changes in Accretable Yield
The following table presents changes in the accretable yield for the years ended December 31, 2018 and 2017 (in thousands):
 
 
Year Ended December 31,
 
 
2018
 
2017
Accretable yield, beginning of period
 
$
2,483

 
$

Additions
 

 
3,481

Accretion recognized in earnings
 
(2,761
)
 
(998
)
Net reclassification from nonaccretable difference
 
727

 

Accretable yield, end of period
 
$
449

 
$
2,483